Ki-Deok Shin

Title: Ki-Deok Shin: Innovator in Cancer Treatment

Introduction

Ki-Deok Shin is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer. His innovative work focuses on the use of diaryl-isoxazole derivatives, which have shown promise in inhibiting cancer metastasis.

Latest Patents

Ki-Deok Shin holds a patent for "Pharmaceutical compositions of diaryl-isoxazole derivatives for the prevention and treatment of cancers." This invention relates to a pharmaceutical composition that utilizes diaryl-isoxazole derivatives as an effective ingredient. The derivatives are designed to inhibit the metastasis of breast cancer cell lines and angiogenesis. This makes them valuable not only as a metastasis inhibitor but also as a potential treatment for various angiogenesis-related diseases, including cancers, rheumatoid arthritis, psoriasis, and eye-related angiogenesis diseases.

Career Highlights

Ki-Deok Shin is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to focus on groundbreaking research that aims to improve cancer treatment options. His dedication to innovation in the pharmaceutical field has positioned him as a key figure in cancer research.

Collaborations

Ki-Deok Shin has collaborated with notable colleagues, including Byoung-Mog Kwon and Kwang-Hee Son. These partnerships have fostered a collaborative environment that enhances the research and development of effective cancer treatments.

Conclusion

Ki-Deok Shin's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work not only addresses critical health challenges but also paves the way for future research in the field.